06/12/2026 | Press release | Distributed by Public on 06/12/2026 09:30
Tags:
The FTC sued multilevel marketer Amare Global Holdings Inc. and three of its principals for misrepresenting to parents and other consumers that its dietary supplements marketed for children and adults could treat or cure health conditions such as depression, anxiety and ADHD, and for misleading its seller recruits about their potential earnings as "brand partners."
The Federal Trade Commission has asked a federal court to hold in contempt dietary supplement provider Amare Global Holdings as well as its former Chief Science Officer Shawn Talbott and two other individuals over allegations they violated an FTC order in the Window Rock case that banned Talbott and those who work with him from making false, deceptive or unsubstantiated health claims.